Johnson & Johnson Non-Current Deferred Revenue (Quarterly) Trends

Johnson & Johnson (JNJ)

204.39 -1.36 (-0.66%) USD | NYSE | Jan 09, 16:00

204.96 +0.57 (+0.28%) Pre-Market: 08:18

View Non-Current Deferred Revenue (Quarterly) for JNJ.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Gilead Sciences, Inc.	--
Eli Lilly & Co.	--
Regeneron Pharmaceuticals, Inc.	Upgrade
Protagonist Therapeutics, Inc.	--